Patricia Tyson

Patricia Tyson serves as a key procurement lead within the Defense Health Agency, overseeing the acquisition of critical pharmaceutical and clinical support solutions aligned with the agency’s mission to ensure operational medical readiness for uniformed personnel, retirees, and their families. She manages complex contract actions centered on the manufacturing and distribution of sterile pharmaceutical preparations, supporting the DHA’s strategic priorities in pharmaceutical supply chain resilience and clinical continuity. Her acquisitions are highly specialized, focusing on end-to-end pharmaceutical lifecycle management, including formulation, packaging, and regulatory-compliant delivery systems essential for military medical operations worldwide. Tyson maintains consistent working relationships with a select group of specialized vendors, including Dependable On-Site Scan & Shred, Inc., Hanith Bioscience, LLC, Livion Technology, LLC, I-2-I Solutions, Inc., and Draeger Inc. These contractors provide niche capabilities in pharmaceutical manufacturing, biologics handling, medical device integration, and clinical logistics. Her procurement approach emphasizes technical proficiency, regulatory adherence, and supply chain reliability, fostering long-term partnerships with firms demonstrating proven expertise in Defense Department-compliant pharmaceutical production and distribution protocols. Tyson’s contracting portfolio reflects a strict focus on open competition, with 100% of awards issued under no set-aside classifications. This indicates a deliberate preference for sourcing from the most technically capable vendors regardless of socioeconomic status, prioritizing mission-critical performance and compliance over socioeconomic targeting. While small business participation is not formally incentivized in her portfolio, all awards are competitively procured under full and open procedures consistent with DOD acquisition regulations. Her primary procurement activity is concentrated in NAICS 325412—Pharmaceutical Preparation Manufacturing—reflecting deep technical expertise in sterile injectables, compounded medications, and controlled-substance formulations. She procures high-integrity pharmaceutical products requiring cGMP compliance, cold chain logistics, and FDA-registered manufacturing environments, ensuring that deployed medical units receive safe, effective, and mission-ready therapeutics.